NCT01683123View on ClinicalTrials.gov

Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT

CompletedOBSERVATIONAL
Enrollment

143

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

October 31, 2012

Conditions
Acute Myeloid LeukemiaMyelodysplastic SyndromeMyeloproliferative DisordersChronic Myeloid Leukemia
All Listed Sponsors
lead

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

OTHER

NCT01683123 - Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT | Biotech Hunter | Biotech Hunter